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doi:10.1016/j.ejvs.2008.11.008Abstract Objectives: To describe our experience of treating juxtarenal (JRAAA’s <4 mm
neck) and thoracoabdominal aortic aneurysms (TAAA’s) using fenestrated and branched stent
graft technology.
Design: Prospective single centre experience.
Methods: Since 2005, 29 fenestrated/branched procedures have been performed. 15 patients
are studied with JRAAAs (nZ 7; median neck length 0 mm (IQR 0e3.8)) or TAAAs (type I
(nZ 2), III (nZ 2), IV (nZ 4)). ASA grade III in 12/15. Maximum diameter of aneurysm
64 mm (56e74 mm). Aneurysms were excluded using covered stents or branches from the main
body to patent visceral vessels (40 target vessels total). Pre-operative and follow-up CT scans
(1, 3, and 12 months) were analysed by a single Vascular Interventional Radiologist.
Results: Technical success for cannulation and stenting of target vessels was 98%. In-hospital
mortality was 0%. One patient underwent conversion to open repair. Five had major complica-
tions including one paraplegia (type III TAAA) with subsequent recovery. Median length of stay
was 9 days (IQR 7e18.75).
At a median follow-up of 12 months (9e14), CT confirmed 36/37 (97%) target vessels remain
patent. Sac size increased>5 mm in one patient only. There were no type I endoleaks, three type
II endoleaks (one embolised, two under surveillance) and three type III endoleaks (two success-
fully treated percutaneously, one aneurysm ruptured 18 months after endografting and died).
Conclusion: In selected patients, fenestrated and branched stents appear to be a safe and effec-
tive alternative to surgery for juxtarenal and thoracoabdominal aneurysms. The complication and
mortality rates are low. The long-term durability of this procedure, however, needs to be proven.
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176 C.D. Bicknell et al.Introduction a proposed open procedure that is high risk may be plannedWith recent advances in endovascular technology, endo-
vascular aneurysm repair (EVAR) has become an attractive
alternative to open surgery for infrarenal aortic aneurysms
with significantly reduced 30-day mortality and comparable
long-term outcomes. Approximately 55% of infrarenal
aneurysms are treatable by EVAR1 with newer devices.
Further development of this technology has led to the
production of fenestrated and branched stents to treat
aneurysms previously unsuitable for standard EVAR. The
Zenith stent (Cook Medical Inc, USA) is CE marked for
aneurysms with an infrarenal neck of between 4 and
11 mm. The efficacy of these custom-made fenestrated
stents for the treatment of short-necked infrarenal
abdominal aortic aneurysms has been well described. This
procedure may benefit in those patients selected to
undergo fenestrated grafting compared to open repair
candidates.2e6
These stents can also be used to treat juxtarenal aneu-
rysms (JRAAA’s) and thoracoabdominal aortic aneurysms
(TAAA’s) involving the visceral segments. Although the
procedure may be more complex, involving fenestrated
stenting of three or more vessels, the advantages for
patients who would otherwise require a suprarenal or
supracoeliac aortic clamp may be important. The proce-
dure is currently developing and gaining acceptance. We
describe our early experience treating these more complex
aneurysm configurations by examining our experience with
fenestrated devices for juxtarenal and thoracoabdominal
aneurysms.
Definitions
Thoracoabdominal aneurysms were classified using the
Crawford classification (Fig. 1). All aneurysms that origi-
nated at or less than 4 mm below the lowest renal artery
were described as juxtarenal.
Procedure
All patients with complex aneurysmal disease that were
present to St Mary’s Hospital are considered for fenestrated
stent grafting in a multidisciplinary forum. Pre-procedure
planning is conducted using a CT angiogram carried out on
a 64 slice Philips Brilliance Scanner (using bolus tracking,
100 mls contrast, 2 mm slice thickness with 1 mm recon-
structions. Rotation time 0.65 s) Complicating factors in
fenestrated stent grafting include small, tortuous iliac
arteries, which cause significant problems with control of
catheters and rotation of the graft; thrombus around the
visceral vessel origin; severe stenosis of visceral arteries;
multiple renal vessels and tortuosity/angulation of the
aorta above or at the level of the fenestrated segment,
which can lead to significant misalignment of fenestrations
with target vessels. The presence of a previous aortic graft
does not exclude patients from aneurysm repair but the
graft may be tortuous, which makes the procedure difficult,
as mentioned above. Patients are excluded from fenes-
trated stent grafting if complicating factors are present and
an operative approach is suitable. Conversely, in those withfor stenting despite these difficulties. For those that are
suitable, custom-made fenestrated devices based on the
Zenith platform (Cook Medical Inc, USA) are produced from
computerised tomographic data with bespoke fenestrations
at the level of the target vessels. This stent needs to be
carefully planned before construction and both these
processes add to the length of time required before
stenting. At our institution we plan the fenestrated stents
in principal and request.
Procedures were performed in an angiography suite
(Philips Integris) that is suitable for open operative proce-
dures. This ensures the best image quality, which is of
paramount importance in these complex interventions.
The technique of fenestrated stent graft placement is
well described in previous publications2e6 and is shown in
Fig. 2(aee). In thoracoabdominal aneurysms, there are
usually 3 or 4 fenestrations that require covered stent
placement. If the anatomy is suitable then we incorporate
a branch into the device for the coeliac or SMA vessels. This
short, downward cuff from the main body is accessed with
a wire via the arm and extended using a covered stent. For
fenestrated stent grafting of juxtarenal aneurysms we use
covered stents if the aorta is parallel walled for less than
4 mm below the vessel, so that the lowest renal artery stent
is always covered, but the higher may be uncovered.
For thoracoabdominal aneurysms, spinal cord drainage is
routine except when contraindicated. We place spinal
drains before surgery and maintain the cerebrospinal fluid
pressure at 10 mmHg with the patient lying flat and
drainage into a reservoir 13 cm above the cord.
Patients and Methods
Data was collected from 2005 to date by means of
a prospectively collected database. All patients undergoing
fenestrated and/or branched stent grafting at St Mary’s
hospital were included into the database. Patient co-
morbidity, technical stent data, in-hospital mortality and
complications were all recorded. Details of follow up and
subsequent procedures were also collected. Patients with
fenestrated grafts introduced for juxtarenal and thor-
acoabdominal aneurysms were studied from this database.
Computerised tomography (CT) scans were analysed by
a Consultant interventional radiologist. The aneurysm
morphology was determined from pre-operative scans.
Neck length, angulation and presence of thrombus were
determined for each of the infrarenal aneurysms. Follow-up
scans were reviewed and reported for sac expansion,
endoleak and patency of target vessels.
Over the study period 29 procedures were performed. Of
these, 15 patients had juxtarenal (nZ 7) or thor-
acoabdominal aneurysms (two type I, two type III and four
type IV TAAAs) and were included in the study group.
Patient demographics are listed in Table 1. The aneurysm
morphology assessed by a single consultant interventional
radiologist with an interest in endovascular aneurysm
repair is recorded in Table 2.
In these 15 grafts, 39 fenestrations and one branch were
utilized in an attempt to revascularise 40 target vessels.
Thirty-three covered (Advanta V12 (Atrium, USA)) and 6
uncovered (Primus GPS, ev3 Europe SAS) stents were
Figure 1 The Crawford classification for thoracoabdominal aneurysms and juxtarenal aneurysms (as defined in this paper by
a neck length of less than 4 mm).
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details of vessels stented are included in Table 3.
Results
Technical success
This procedure was a technical success in 14 of 15 patients
(93%). Thirty-nine out of 40 target vessels (98%) were
successfully stented through the femoral (37 stents) or
brachial (2 stents) routes. Completion of angiograms
following the successful procedures showed no evidence of
endoleak after any of the procedures.
The median procedure time was 375 min (interquartile
range 300e395 min) and median screening time was 111 min
(83.5e145). The median volume of contrast injected was
136 mls (100e200). Median peak plasma creatinine after the
procedure was 116 Umol/L (108e179). Plasma creatinine on
discharge was a median of 103 Umol/L (89e163).
One patient with a 10 cm juxtarenal aneurysm with
severe angulation of the aorta at the renal level and asso-
ciated significant coronary artery disease underwent
fenestrated stent grafting prior to coronary artery revas-
cularization. During the procedure the right renal artery
could not be cannulated (believed to be as a result of
orientation issues between the graft and target vessel).
After a lengthy procedure the graft was deployed without
cannulation of this vessel and a covered stent was placed
into the left renal artery and an uncovered stent into the
SMA. The patient was transferred to intensive care with
a view to subsequently attempting cannulation via the
brachial route. Before this was able to take place, on day
two following the original procedure, the aneurysm
ruptured and the patient underwent open tube graft repair.
The aortic clamp was placed in a supracoeliac position for
endograft explantation and an infrarenal anastomosis was
fashioned. He was discharged home after a protracted
intensive care stay during which he required haemofiltrationand had a prolonged respiratory wean. This was our only
conversion to open surgery.
In one subsequent patient a similar situation has arisen,
with failure to cannulate and stent the right renal orifice.
This patient underwent CT scanning, following deployment
of covered stents to the other renal artery and SMA, to
further delineate the anatomy. The patient subsequently
returned to the angiography suite 12 h later and underwent
successful stenting of the renal vessel via the brachial
approach. Of note, this patient had a significantly tortuous
infrarenal tube graft that was thought to have restricted
control of the catheters whilst attempting to cannulate the
target vessel. Aside from these orientation issues, only
minor difficulties were experienced with graft orientation
in relation to the target vessels, requiring small rotational
adjustments of the graft during vessel cannulation.
Morbidity and mortality
There was no 30-day or in-hospital mortality in this group.
Median hospital stay was 9 days (7e19). One patient, after
a prolonged type IV TAAA stent graft placement, required
fasciotomies for an acute compartment syndrome the same
day as stent grafting and underwent a Hartmann’s opera-
tion for colonic ischaemia 2 days after the procedure. He
went on to develop multiorgan failure requiring respiratory
support and haemofiltration on a temporary basis. He then
made good recovery. One patient after endovascular repair
of her type III TAAA developed paraplegia which partially
recovered over the subsequent six months. This patient
developed paraplegia late after surgery despite the use of
cerebrospinal fluid drainage. Another developed significant
line sepsis requiring high dependency care and intravenous
antibiotic therapy. One patient thrombosed the left limb of
a bifurcated graft and developed short distance claudica-
tion, requiring femoro-femoral cross over bypass grafting.
This thrombosis was thought to be secondary to a kink in
the stent.
Figure 2 (a) The device is placed at the level of the visceral vessels under fluoroscopic imaging with the markers on the graft
demonstrating the correct orientation and alignment of the fenestrations with the visceral vessels (which have been previously
identified with fluoroscopic imaging). This case of a type III thoracoabdominal aneurysm used three stents into the renal vessels and
superior mesenteric artery (SMA) as the celiac trunk was occluded. (b) The fenestration/ostial interfaces are bridged with extra
stiff wires allowing guide catheters to be placed into the vessels. This allows easy passage of covered stents into the vessels. This
figure shows guiding catheters and stiff wires in the renal vessels and a cobra catheter cannulating the SMA through the appropriate
fenestration. (c) Through the guide catheters, stents (PTFE covered in the case of TAAA’s) are placed, which are deployed to secure
the main body aortic side wall to the visceral ostium and bridge the aneurysm sac. This image shows contrast in the SMA stent and
SMA and both renal stents in place. (d) After all the target vessels have been stented, the distal sections of this composite device
are finally placed and deployed (bifurcated for iliac fixation and tubular in aneurysms with a distal landing zone in the aorta or in
a previous aortic tube graft). This image shows a completion angiogram. All vessels have been successfully stented and there is
exclusion of the aneurysm. (e) CT reconstruction of the same patient during follow up assessment.
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significant coronary disease deemed unsuitable for percu-
taneous coronary intervention and too high risk for coro-
nary bypass had a myocardial infarction following aortic
stenting with no significant sequelae.
Follow up
The median follow up for this group is 12 months (inter-
quartile range 9e14 months). Thirty-six of the 37 (97%)
vessels in the successfully stented group remain patent on
follow-up CT scanning. One coeliac stent was occluded with
an amplatzer occluder after dislocation of the stent leading
to a type III endoleak (discussed below). The maximum sac
size has decreased in size by more than 5 mm in 5 of 11
patients who have had follow up scans after 3 months. Only
one patient has had an increase in sac size greater than
5 mm. This was discovered when he presented with
a ruptured aneurysm (discussed below). The median change
in sac size was 2 mm (5 to þ2 mm).
Over the follow-up period no patients developed a type I
endoleak. Three patients developed type II endoleaks, twoof which are under surveillance with a decreasing aneurysm
sac size on follow-up CT examination. One patient with
a type I TAAA had a type II endoleak from a significant
branch of the right subclavian artery, filling the proximal
sac. This branch was identified by angiography, cathe-
terized selectively and embolised successfully.
Three patients developed type III endoleaks. In one
patient this was secondary to the dislocation of the
coeliac stent from the target vessel, with free flow of
contrast into the aneurysm sac. This was recognised on
the first surveillance CT scan and was most probably due
to the coeliac stent not extending far enough into the
target vessel. This was treated by amplatzer occlusion of
the celiac stent and sacrifice of the coeliac arterial
supply. The patient tolerated this well and suffered no
sequelae as a result. Another patient with a type IV TAAA
developed a type III endoleak at the join between the
covered renal stent and fenestration. This required
a further covered renal stent to be placed to seal this leak
with an excellent angiographic result. The final patient
presented 18 months after an uncomplicated juxtarenal
AAA fenestrated graft with an acutely ruptured aneurysm
Table 2 Aneurysm CT data for juxtarenal and thor-
acoabdominal aneurysm stent grafts (nZ 14). Median
values are shown with interquartile ranges in parentheses or
number of patients with percentage of entire study group
where appropriate
Aneurysm type
Juxtarenal aneurysm 7 (50%)
Neck length 0 mm (0e3.8 mm)
Type I TAAA 2 (14%)
Type III TAAA 2 (14%)
Type IV TAAA 4 (27%)
Morphology
Maximum diameter 64 mm (56e74 mm)
Thrombus at neck 5 (33%)
Angulation 15 (8.75e23.5)
Iliac vessels
Left iliac diameter 17 mm (13.7e22.8 mm)
Right iliac diameter 15 mm (11.7e18.3 mm)
Table 1 Patient demographics for juxtarenal and thor-
acoabdominal aneurysm stent grafts (nZ 14). Median
values are shown with interquartile ranges in parentheses or
number of patients with percentage of entire study group
where appropriate
Age 70 years (67e73 years)
Sex 12 men (80%)
Presentation
Asymptomatic presentation 15 (100%)
Risk factors
Hypertension 13 (87%)
Diabetes 2 (13%)
Smoking 11 (73%)
Statin therapy 13 (87%)
Co-morbidity
ASA grade >3 12 (80%)
Peripheral vascular disease 2 (13%)
Previous aneurysm surgery 3a (20%)
Coronary artery disease 7 (47%)
Coronary intervention
(PCIb or CABGc)
5 (33%)
Creatinine 109 Umol/L (93e120 Umol/L)
Abnormal renal function 3 (20%)
ICA stenosis >70% 0 (0%)
a One patient with a type III TAAA had previous arch
replacement, two patient with type IV TAAAs had previous open
infrarenal tube and open aorto bi-iliac grafts.
b Percutaneous coronary intervention.
c Coronary artery bypass grafts.
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iliac limb of the graft. This rupture occurred 4 months
after a routine surveillance scan that had shown
a decreasing sac size and no evidence of endoleak, with
no evidence of insufficient overlap between components.
Expedient treatment was mandatory; we were not able to
arrange the facilities for immediate endovascular iliac
extension grafting, and so the patient underwent open
repair of the aneurysm with a suprarenal clamp, explan-
tation of the device and tube graft repair. This patient
died in intensive care.
There was one further death in this group of patients
during the follow-up period. One patient after juxtarenal
fenestrated repair presented 4 months later with an acute
type A dissection of the aortic arch and died following
cardiac surgery. The origin of the dissection was far
removed from the stent graft landing zone and was not
considered to be related.
Discussion
Open treatment of juxtarenal and thoracoabdominal
aortic aneurysms involving major abdominal branches of
the aorta is significantly more challenging compared to
infrarenal surgery, with a large increase in mortality and
complications.7,8 At St Mary’s, we repair the majority of
juxtarenal and type IV TAAAs via an open approach utilising
a suprarenal or supracoeliac clamp and subsequent tubegraft repair. For those more complex aneurysms (types I, II
and III) we have pioneered a hybrid approach to repairing
these complex aneurysms. This utilizes both open and
endovascular procedures with retrograde revascularisation
of the visceral vessels and endovascular exclusion of the
aortic aneurysmal site. This procedure has subsequently
decreased mortality rates, but is still a major surgical insult
and patients still require long ITU and hospital stays.8 A
total endovascular approach to the treatment of these
aneurysms is attractive and may have significant benefits in
terms of mortality, morbidity and hospital stay when
compared to the open operation. Our series demonstrates
that it is possible to achieve a low mortality rate and minor
complication rate when compared to standard open surgery
results. Clearly, however, this group of patients is highly
selected has more favourable anatomy than those that
undergo open surgery and this needs to be taken into
account. On the contrary, these patients are sometime
selected for fenestrated stenting based on significant
co-morbidity that precludes open repair. In this situation
the anatomy may be less than favourable for stenting but
stenting may be the favoured approach.
Other significant series of fenestrated and branched
stent grafts have shown similar results with respect to
mortality and complications. Roselli et al. have recently
reported a series of seventy-three patients who underwent
endovascular repair of thoracoabdominal aortic aneurysms
with fenestrated stent grafts.9 Just over 60% of these
aneurysms were type IV TAAAs. This group achieved tech-
nical success in over 90% of cases with a mortality rate of
5.5%. The complication rate was low, occurring in 14% of
patients, with two patients developing paraplegia. Chuter
has reported 22 cases of thoracoabdominal aneurysms using
self-expanding covered stents to connect the caudally
directed cuffs of an aortic stent graft (branched grafts)
with the visceral branches of a TAAA.10 The covered stents
are all inserted via the brachial route. This method appears
equally effective in producing low mortality rates as only
two patients died perioperatively in this series. An added
Table 3 Stented target vessels during the endovascular aneurysm repair of juxtarenal and thoracoabdominal aneurysms
Covered stent Uncovered stent Branch Scallop
Coeliac 1 Two vessels occluded on presentation 0 1 4
SMA 7 1 0 5
Right renal 10 Unable to cannulate
one right renal artery
3 One in type I TAAA Two in JRAAA
higher renal artery
0 1
Left renal 14 One accessory left renal artery 2 One in type I TAAA One in
JRAAA higher renal artery
0 0
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that previous open repair does not seem to increase the
risk. Of a series of 9 para anastomotic aneurysms of the
aorta, technical success was achieved in all cases, with no
mortality.11
We experienced no type I endoleaks, presumably due to
the enhanced landing zone created by utilising the aorta
around the level of the visceral arteries or in the thorax as
well as fixation by means of stents through the fenestra-
tions. This configuration has been shown experimentally to
increase the stability of the proximal graft12 and seems to
be effective. Unsurprisingly the majority of our significant
endoleaks were type III in nature. This must be expected
due to the multi-modular nature of these grafts. Most of
these endoleaks, however, can be dealt with by a relatively
simple percutaneous technique. Unfortunately one patient
ruptured after a type III endoleak from an iliac limb dislo-
cation. Clearly, whilst type I endoleaks may not be so
prevalent in fenestrated grafts, attention must be paid to
overlap between the modular components of this graft to
ensure maximal stability in the mid portion of the graft.
Although the follow-up period of our series was a median
of 12 months we experienced no unintentional loss of any of
the 37 target vessels stented. Although the stents are placed
into relatively small visceral branches, the patency rates
seems to be good, certainly in the medium term. Others have
observed similar patency rates when thoracoabdominal
aneurysms are stented either using a fenestrated or
branched graft method.9,10 This is encouraging, but further
observation is mandatory, as the morphology of the excluded
aneurysm changes over many years. In addition to this posi-
tive observation, all aneurysm sacs have remained stable or
decreased in size after stenting, bar the patient who quickly
dilated following occurrence of a type III endoleak. This can
also be observed in larger series where no stent migration or
aneurysmal growth was seen.9,10
Whilst this technique to extend the role of stent grafting
for aneurysms to include juxtarenal and thoracoabdominal
aneurysms is attractive, it does have its limitations. The
bespoke nature of these grafts means that there are
inherent time delays in manufacture and they are therefore
unsuitable for urgent and emergency cases. In complex
aortic aneurysms, the strategy for fenestrated and
branched endograft planning is difficult and often requires
close discussion between the clinical team and
manufacturing partner. A lack of experience can add to the
planning and manufacture time significantly.
Further development of the technique may need to
include methods to perform ‘‘in situ’’ fenestration of grafts
(puncturing the graft at the desired level and stenting of thetarget vessel) but the development of the technology for this
is at an early stage.13e15 Another prohibitive consideration is
that of cost. The custom-made nature of these grafts is
expensive which may hinder its widespread applicability.
Lastly, this is a very labour intensive process that requires
a great deal of expertise. Procedure times are long and cases
can be very demanding, especially when all visceral vessels
need stenting. Also anatomical difficulties such as iliac
tortuosity can hinder the operator further, causing major
problems with ‘‘torquing’’ catheters. Suitable training for
these new and complex techniques will also be time
consuming. We performed seven cases with the help of
a proctor to learn the techniques associated with fenestrated
stent grafting including implantation and planning tech-
niques. Recommendations are hard to give for all clinicians
when considering how to learn the techniques associated
with fenestrated stent grafting. A detailed knowledge of
thoracoabdominal aneurysm disease, endovascular treat-
ment and experience with open surgical techniques is
essential when deciding between an open surgical and totally
endovascular approach to treat the individual patient.
Conclusions
In selected patients, fenestrated and branched stent grafts
appear to bea safe and effective alternative to surgery for true
juxtarenal and thoracoabdominal aneurysms. The complica-
tion and mortality rates after surgery are low. The long-term
durability of this procedure, however, needs to be proven.
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